Skip to content

lopinavir-ritonavir

Interactions

Vardenafil/Selected Protease Inhibitors

This information is generalized and not intended as specific medical advice. Consult your healthcare professional before taking or discontinuing any drug or commencing any course of treatment.

Medical warning:

Severe. These medicines may interact and cause very harmful effects and are usually not taken together. Contact your healthcare professional (e.g. doctor or pharmacist) for more information.

How the interaction occurs:

Protease inhibitors may slow down how quickly your liver processes vardenafil. Vardenafil may speed up how quickly your liver processes your protease inhibitor.

What might happen:

The amount of vardenafil in your blood may increase and cause harmful effects. The amount of protease inhibitor in your blood may decrease and it may not work as well.

What you should do about this interaction:

Contact your healthcare professionals (e.g. doctor or pharmacist) right away about using these medicines together. If your are taking indinavir, do not take more than 2.5 mg of vardenafil every 24 hours. If you are taking lopinavir or ritonavir, do not take more than 2.5 mg of vardenafil every 72 hours.Get medical help right away if you experience a painful or prolonged erection. Let your doctor know if you experience fainting, dizziness, or changes in vision.Your healthcare professionals may already be aware of this interaction and may be monitoring you for it. Do not start, stop, or change the dosage of any medicine before checking with them first.

References:

1.Levitra (vardenafil hydrochloride) Canadian prescribing information. Bayer, Inc. October 24, 2006.

2.Levitra (vardenafil hydrochloride trihydrate) UK summary of product characteristics. Bayer plc December 20, 2006.

3.Levitra (vardenafil hydrochloride) US prescribing information. Bayer Pharmaceuticals Corporation August, 2013.

4.Crixivan (indinavir sulfate) US prescribing information. Merck & Co., Inc. February, 2011.

5.Kaletra (lopinavir/ritonavir tablets) US prescribing information. Abbott Laboratories January, 2013.

6.Norvir (ritonavir) US prescribing information. Abbott Laboratories November, 2012.

7.Aptivus (tipranavir) US prescribing information. Boehringer Ingelheim Pharmaceuticals, Inc. February, 2012.

Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, expect as may be authorized by the applicable terms of use.

CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.

More about Drugs and Medications

Newsletters

Subscribe to free WebMD newsletters.

  • WebMD Daily

    WebMD Daily

    Subscribe to the WebMD Daily, and you'll get today's top health news and trending topics, and the latest and best information from WebMD.

  • Men's Health

    Men's Health

    Subscribe to the Men's Health newsletter for the latest on disease prevention, fitness, sex, nutrition, and more from WebMD.

  • Women's Health

    Women's Health

    Subscribe to the Women's Health newsletter for the latest on disease prevention, fitness, sex, diet, anti-aging, and more from WebMD.

By clicking Submit, I agree to the WebMD Terms & Conditions & Privacy Policy

URAC: Accredited Health Web Site TRUSTe online privacy certification HONcode Seal AdChoices